Advertisement

Suniel Shetty enters into a strategic collaboration with O2Cure


Suniel Shetty enters into a strategic collaboration with O2Cure
SHARES

It is not new for Bollywood icon to venture into a business venture. In the past too there are many actors that have made strategic investments in the business. Bollywood actor, entrepreneur & fitness enthusiast, Suniel Shetty is the latest to join the bandwagon. He has entered into a  strategic collaboration with O2Cure; an establishment under Zeco Aircon Ltd. to introduce their air purification product line to the Indian markets.

O2Cure provides RGF's (a US-based environmental design and manufacturing company) patented REME with PHI-Cell technology that has been successfully tested by CCMB-CSIR virology lab in India for reduction of SARS-CoV 2 by 97.48 per cent and by Innovation Bio-Analysis lab in USA for reduction of SARS-CoV-2 virus by 99 per cent from air and surfaces. Their products also prevent other air contaminants like bacteria, viruses, germs, gases, particles, dust, pollen, and other hazardous pathogens.

Excited about the association with O2Cure, Suniel Shetty says “I felt a sense of security & honesty when I  came across O2Cure products. Unlike other air purifier brands in the market, these products are really helpful in not  only controlling airborne diseases but also neutralising the novel coronavirus (SARS-CoV-2) up to 99 per cent.”

Kartik Singhal, Founder of O2Cure says “We are pretty excited to have Shetty in our team and feel that with his inclusion the team strength has grown multi folds. Anna brings with him years of experience in the media & entertainment industry & has created several successful brands and we are certainly looking to capitalize on this as a business. We are hopeful to push O2Cure not  just as a brand that can neutralise SARS-CoV-2 virus but as a necessity to your homes.”

O2Cure carry’s forward over three decades of work in R&D by their parent company Zeco Aircon in air management systems. The brand is also planning to introduce a new product line in the market that will focus on countering all types of air pollutants from indoor & outdoor air and surfaces. The future growth expected by O2Cure is a 20-25 per cent year-on-year growth in terms of revenue which is in light to the demand witnessed for their current product line. O2 Cure products and technology focus on neutralising viruses, bacteria, PM levels, microbial, thereby reducing cross-contamination and making indoor air healthier to breathe.

RELATED TOPICS
Advertisement
MumbaiLive would like to send you latest news updates